Forbes  Oct 27  Comment 
Dane Miller, founder of Biomet, had a hard time keeping up with the IT world. Trained as a biomechanical engineer, he was a brilliant CEO and inventor, but never pretended that he knew it all. When the company was buying a half million dollars...
Benzinga  Oct 2  Comment 
Biomet today announced the completion of its previously announced offering of $825 million aggregate principal amount of senior notes due 2020 (the “Additional Senior Notes”), at an issue price of 105.000% plus accrued interest from August 8,...
StreetInsider.com  Jun 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Medical+Equipment+Stocks+Rally+as+BioMet+Shows+Solid+US+Growth+%28SYK%29+%28ZMH%29+%28WMGI%29+%28ARTC%29/7520486.html for the full story.
Wall Street Journal  Apr 11  Comment 
Biomet reported modestly higher sales of hip and knee replacements for its most recent quarter, providing hope to investors that the orthopedic market may be improving.
Wall Street Journal  Apr 3  Comment 
Biomet made a binding offer to acquire the global trauma business of J&J's DePuy Orthopaedics for about $280 million in cash.
MarketWatch  Apr 3  Comment 
Biomet Inc. said Tuesday it'll pay $280 million in cash to buy the trauma business of DePuy Orthopaedics Inc. The privately-held Warsaw, Ind., medical products company said the deal will provide it with a "much stronger presence int he global...
Wall Street Journal  Mar 26  Comment 
Biomet, a maker of orthopedic products, agreed to pay more than $22 million in penalties to settle U.S. allegations that it bribed doctors in countries like Brazil and China over a period of years.
Mondo Visione  Mar 26  Comment 
The Securities and Exchange Commission today charged Warsaw, Ind.-based medical device company Biomet Inc. with violating the Foreign Corrupt Practices Act (FCPA) when its subsidiaries and agents bribed public doctors in Argentina, Brazil, and...
MarketWatch  Mar 26  Comment 
The Securities and Exchange Commission on Monday charged medical device firm Biomet Inc. with violations of the Foreign Corrupt Practices Act for bribing public doctors in Argentina, Brazil, and China. The SEC said that company's lawbreaking went...
Wall Street Journal  Apr 12  Comment 
Biomet posted soft replacement-joint sales in its fiscal third quarter, raising fresh questions about an orthopedics market stung by an uncertain global economy.




RELATED WIKI ARTICLES
 


You may also be interested in articles related to Biomet (BMET):

Competition




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki